Xtant Medical (NYSE:XTNT) said today it inked a licensing agreement with Sites Medical for its OsteoSync Ti porous titanium scaffold technology. Sites Medical’s OsteoSync Ti technology is designed with a high friction coefficient for high implant stability and open pore geometry and micro-texturing for bone ingrowth, the company said. “We are very excited to work with Sites […]